© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Back in the 1960s, furaltadone rolled out onto the global veterinary pharmaceuticals stage as part of the nitrofuran family. Chemists at Bayer synthesized this antibiotic, looking for new ways to fight off persistent bacterial diseases threatening livestock. Countries in Europe and Asia quickly picked it up for farm use. Its broad-spectrum action gave producers a tool to increase productivity and deal with common infections in poultry, cattle, and aquaculture. Regulatory frameworks during these years largely lacked today’s rigor, so furaltadone saw extensive use across continents, boosting yields and impacting food security for expanding populations. Later, as food safety and antibiotic resistance stories caught public attention, government oversight increased, but furaltadone’s imprint lingers in the history of veterinary science.
Furaltadone, developed as an antibacterial compound, found its home in animal husbandry. Available mostly as a fine, yellowish powder or granulate, it mixes with feed or water. Its primary customers, farmers and veterinary labs, valued it for ability to restrict the spread of pathogens in poultry and fish. With regulations tightening, its supply shifted from widespread distribution to more specialized markets, often for research or controlled veterinary settings. Today, furaltadone products cater mainly to scientific research and niche veterinary needs, rather than mass agriculture.
With a chemical formula of C13H13N5O6, furaltadone stands out among nitrofuran antibiotics. Its crystalline yellow or orange tint is practical for blending with animal feed, though humidity and sunlight degrade its effectiveness. At room temperature, it remains stable, but its structure breaks down when exposed to alkaline or strongly acidic conditions. Solubility becomes a factor in preparation: it dissolves well in dimethylformamide, dimethyl sulfoxide, and other polar organic solvents, but sparingly in water. This partial solubility directs how manufacturers handle blending with feed for distribution to animals. The melting point hovers around 241–242°C, so bulk storage in temperate warehouses works without risking decomposition.
Quality control standards for furaltadone products detail purity (typically above 98%) and maximum allowable impurities, like hydrazones or related nitrofuran derivatives. Labels list net content, chemical name, batch number, recommended expiry, and safety precautions, since residue monitoring often triggers legal actions in regulated markets. Given the threat of banned residue accumulation, modern labels must emphasize withdrawal periods and restricted usage. Technical data sheets often include recommended dosing, carrier material information, and clear warnings about potential contamination of human food supplies.
The heart of furaltadone synthesis lies in condensation of 3-(5-nitrofurfurylideneamino)-2-oxazolidinone with semicarbazide hydrate, using ethanol or water as the reaction medium. Controlled heating initiates the bond formation, followed by crystallization. Batch processes dominate, since high-volume production now faces more scrutiny in many regions, limiting process scale. Downstream filtration, drying, and milling yield commercial product suited for compounding in medicated feeds. Details on catalysts and temperature settings get adjusted to optimize yield and reduce unwanted byproducts, crucial for meeting international residue and purity standards.
Furaltadone’s structure allows for reduction and hydrolysis reactions, leading to hydrazone derivatives or breakdown products that inform residue testing in food. Researchers have explored modifications at the furan ring and amino group to improve selective toxicity and reduce residue formation. Some attempts at masking the nitrofuran core aimed to sidestep metabolic pathways responsible for producing potentially carcinogenic byproducts, but most analogs never advanced beyond laboratory trials. Reactivity with nucleophiles underlines the care required during formulation and storage, as unintended side reactions can alter potency and safety.
Furaltadone appears on paperwork around the globe under names such as Furaltadone Hydrochloride, Furoxone, Furofur, Furaltadone HCl, and several brand names derived from original manufacturers. Regulatory databases log synonyms like 5-nitrofurfurylideneamino-2-oxo-oxazolidine, which crop up in research and toxicological profiles. These aliases shape tracking efforts for banned substances in international trade, so supply chain actors must recognize them to comply with import-export controls.
Handling furaltadone in labs and feed mills runs up against a battery of safety considerations. Direct contact risks skin, eye, and respiratory irritation. Staff often require gloves, masks, and eyewear, and dust control features in facilities stop airborne particles from reaching unintended areas. At the research stage, tighter controls prevent cross-contamination with other medicants. Current standards treat furaltadone as a substance of concern, so operations need robust documentation, especially regarding disposal, spill containment, and personal protective equipment. Residue audits by inspectors reinforce these protocols, and penalties for non-compliance crop up in food safety enforcement actions globally.
For decades, veterinary users leaned on furaltadone to manage enteric infections, most often those triggered by E. coli, Salmonella, and Aeromonas in chickens, turkeys, and fish. In integrated aquaculture systems, furaltadone stood out for addressing mass mortality events in carp and tilapia, particularly in regions lacking access to pricier antimicrobials. Overuse drew sharp scrutiny with the rise of residues in human food products. In response, most developed countries banned or severely restricted it in food-producing animals. Still, its research applications persist, providing insight into antimicrobial resistance mechanisms and forensics in illegal veterinary drug tracking.
Scientists have probed every angle of furaltadone’s action mechanism. It disrupts bacterial DNA synthesis, making it broadly active against Gram-negative and Gram-positive pathogens. R&D efforts continually wrestle with the dual needs of veterinary medicine and public health. Legacy studies documented efficacy across varied pathogens, but recent research centers more on tracking residues in food, developing faster detection methods, and evaluating resistance development in bacteria exposed to nitrofurans. Regulatory watchdogs often base future guidelines on these studies, so the pipeline for furaltadone analogs now runs cool, with most work focusing on analytical chemistry and pharmacovigilance. Increased global connectivity puts pressure on research teams to share data and align detection standards, since illegal use of furaltadone drags food exporters into trade disputes.
Animal and cell studies flagged furaltadone metabolites as mutagenic, and possible triggers for carcinogenic changes. These data drove strict bans in the United States, the European Union, and much of Asia for food-producing species. Chronic exposure in lab animals led to DNA adduct formation and higher frequencies of liver and kidney tumors, establishing the risk profile that shadows the compound today. Human epidemiological data remain spare, but enough red flags exist that global public health authorities include furaltadone among substances requiring intense scrutiny. Advances in analytical methods such as LC-MS/MS keep pushing detection limits lower, so even trace residues found in food shipments set off regulatory alarms and product recalls.
With food safety now a front-page concern, furaltadone’s future outside of tightly regulated research settings looks dim. Regulatory bans eliminate the mainstream animal health market, shifting demand strictly to forensic laboratories and academic groups exploring resistance and environmental impact. In some lower-income regions, illicit use may persist, particularly where government enforcement lacks teeth or affordable alternatives don’t reach remote producers. Increasingly, the focus settles on developing better detection technology for supply chain monitoring and piloting residue-free animal husbandry practices. As global antimicrobial resistance challenges intensify, furaltadone serves as both a cautionary tale and a catalyst for new policies that balance animal health with safe, sustainable food production.
Furaltadone isn’t a common name in casual conversation, but it comes up fast in any talk about antibiotics for animals raised for food. Developed as part of the nitrofuran group, this synthetic drug was once a go-to solution for tackling infections in poultry and fish farming. Veterinarians often turned to it when facing tough bacteria or parasites that threatened the health of entire flocks or tanks. The drug could stop the spread of bacterial infections that cause big losses in food operations, and for years, it looked like a simple answer to some thorny industry challenges.
The trouble with furaltadone, and its cousins, runs deep. Research shows that nitrofuran antibiotics can stick around in animal tissues after treatment, meaning consumers risk taking in residues through eggs, meat, or fish. In my own experience reporting on food safety, I’ve talked to experts who worry about chronic exposure, as it links to human health problems like cancer and resistance to important antibiotics. In countries with rigorous food testing, regulators pick up traces at the nanogram level—levels that sound tiny but raise red flags in bulk food markets.
Back in the day, many farmers argued that “a little bit won’t hurt.” They wanted reliable ways to keep animals healthy and avoid major losses to disease outbreaks. Still, society caught on that eating meat with traces of furaltadone could introduce risks, even if each mouthful barely registered. No cut of chicken or fish should come with a side order of worry—it’s meant to nourish, not endanger.
Europe’s food authorities started banning furaltadone decades ago, based on evidence about genotoxic and carcinogenic effects in laboratory studies. The US and Canada followed suit, dropping approval for use in any food-producing animal. Most large economies stopped using the compound, setting up tight border checks for imports. This wasn’t just a political move; lab evidence pointed toward a real threat. Regular tests, funded by governments, discovered illegal residues in batches from countries that hadn’t switched antibiotics.
Across Asia and South America, where some producers stuck to furaltadone longer, farmers faced tough choices. Stopping use often meant dealing with costlier drugs, stricter hygiene rules, or more animal losses to infection. Some industry leaders invested in cleaner environments and vaccination programs. Others tried herbal additives and new feeding strategies. My interviews with aquaculture experts in Southeast Asia show that while the transition was rough, communities eventually cut their antibiotic reliance and turned up the focus on water quality—a long-term win for both public health and sustainable farming.
Buying habits have real power. If retailers demand regular residue testing or require suppliers to prove antibiotic-free practices, compliance goes up. Shoppers want transparency and assurance that dinner won’t bring along unwanted extras. I’ve seen farmers turn to third-party certification and QR codes on packaging; they know trust boosts sales, especially as just one food safety scare can tank a brand’s reputation.
Responsible farming never comes with shortcuts. Managing infection risk today means better animal care, more investment in biosecurity, and smarter diagnostic tools. Furaltadone’s story serves as a reminder that cutting corners eventually costs more than it saves. Building systems to track and trace antibiotic use can keep consumers safer and open up new markets. The payoff—wholesome, worry-free food—matters to us all.
Furaltadone belongs to a group called nitrofuran antibiotics. These drugs have been around for decades, showing up in the toolkit of veterinarians and animal farmers. The main goal behind using furaltadone is to fight off infections in livestock, especially poultry and fish. Back in the day, farmers and producers often reached for it because it seemed to reduce losses from bacterial diseases. The push for higher yields and greater efficiency handed drugs like furaltadone a central role in food animal farming across parts of Asia and Eastern Europe.
Treating animals with furaltadone can bring short-term relief from disease, but the longer story isn’t so rosy. Research has surfaced linking furaltadone to toxic effects inside the bodies of treated animals. This includes a real risk of organ damage—especially to vital organs like the liver and kidneys. There’s also the chance that residues of the drug stick around in animal tissues even after a legally required withdrawal period before slaughter.
Antibiotics used this way contribute to another huge problem: bacteria become tougher over time, learning to resist the drugs. Bacterial resistance can spread far beyond any one farm and winds up turning harmless infections into stubborn, sometimes deadly, threats. In many places, routine use of furaltadone has already cut away at the effectiveness of older antibiotics that used to do the job.
Concerns about furaltadone don’t stop at animals. Eating meat, eggs, or fish treated with furaltadone exposes people to its residues. Studies from Europe and parts of Asia found that nitrofuran residues stick around longer than most people think, and can be hard for routine food safety checks to catch. Even tiny traces that remain may be risky.
Digging into the science, nitrofurans have a reputation for being mutagenic and carcinogenic. That means repeated or long-term consumption could nudge the risk of cancer upward. It doesn’t take a scientist to see that this casts a shadow over the dinner plate—nobody wants a side order of medication with their protein.
The safety concerns have not gone unnoticed. The European Union, the United States, and several other regions completely banned the use of furaltadone in food-producing animals years ago. Public health watchdogs like the World Health Organization voiced strong warnings, citing documented risks. These bans don’t just cover giving the drug to animals—they target any trace of the chemical in products that show up on supermarket shelves.
Enforcing these bans proves tricky, particularly where veterinary oversight is looser or the rules haven’t kept up with international standards. In some local markets, furaltadone products turn up, typically labeled for aquarium or small animal use, with little or no warning about the danger of consuming animals exposed to these drugs.
Looking beyond furaltadone means clearer labeling, better veterinary training, and more sensitive testing for food products. Supporting farmers who switch to safer, proven antibiotics or focus on preventive animal health gives everyone better odds of avoiding the same mistakes with other medicines. Stronger international cooperation ensures food imports meet consistent standards, so shoppers can trust what lands on their plates.
Protection of both animals and humans relies on regular monitoring, practical guidance for food producers, and consumer awareness campaigns. Choosing health over convenience shapes a food system that stays trustworthy for everyone.
Many folks in farming communities have heard about furaltadone. It’s an old antibiotic used mainly for animals, including chickens and fish. The substance fights bacteria, but it’s far from a household name unless you’re close to agriculture. Even if someone’s prepping livestock for market, it’s good to remember that every strong medicine can come with its own baggage.
Using furaltadone in animals doesn’t stop at cleaner barns or faster-growing birds. Medicine has pointed out that furaltadone carries real risks, not just to those giving it but to anyone eating the end product. People who handle the powder can develop allergic reactions. Skin contact causes red, itchy rashes. Breathing in the dust sometimes triggers asthma-like symptoms. Eyes can burn and water. Most of these problems show up right away, making it clear that personal protective equipment isn’t just for show in the barn.
The bigger risk lands on the table. Studies have shown that furaltadone leaves residues in meat, eggs, and fish. Family dinners could unknowingly include tiny amounts of this drug. Over time, the World Health Organization and scientific research have linked this antibiotic family, the nitrofurans, to cancer in lab animals. This isn’t meant to start fearmongering around every meal, but it’s not a footnote, either. Europe and other regions banned furaltadone for food animals years ago for this reason.
Whenever antibiotics are used widely, bacteria fight back. It’s a problem that doesn’t just stay on the farm. When resistant bugs survive, they can spread to people. I’ve seen friends in healthcare stress about infections that don’t respond to common drugs anymore. The overuse of medications like furaltadone pushes this process along, and that affects everyone—old, young, sick, or healthy. Resistant bacteria don’t care if you work on a farm or live in the city.
Change in farming practice helps. Some farmers have turned to better hygiene, using vaccines and healthier feed to cut down the need for heavy antibiotics. The FDA and equivalent agencies in other countries keep watch for illegal use, with fines and import restrictions set up to keep out tainted food. On a personal note, I look for country-of-origin labels in the grocery store. Buying local or certified food can reduce risk.
Education plays an important role. When people learn about these issues early, especially those studying animal science or working on farms, it’s easier to pick safer options. Transparency in the food chain brings accountability. Even small producers can keep good records to prove their animals are raised responsibly.
Furaltadone’s side effects go beyond the barnyard. There are health risks to workers, concern about residue and cancer risk in consumers, and antibiotic resistance that threatens everyone. With more awareness and better practices, everyone along the chain can help put safety before short-term gain. These are lessons not just for experts or regulators, but for everyday choices at the market and on the farm.
I’ve spent years working alongside farmers, veterinarians, and public health officials who keep a close eye on antibiotic use in livestock. Furaltadone gets used in animal health mostly for fighting bacterial infections, especially in poultry and fish. The rules have tightened for good reason—misuse means bacteria might get stronger, putting both animal and human health in danger. European regulators banned it a while back, but furaltadone still appears in some countries where regulations aren’t as strict. This raises big questions about who oversees its administration and how we keep everyone safe.
Marketed under different names, furaltadone commonly comes in powder form, mixed with feed or dissolved in water for easy delivery to animals. Getting the dose right matters every time. Overdosing stresses the animal’s organs and leaves residue in meat, eggs, or milk. Under-dosing risks the treatment failing, and lets resistant bacteria develop. In practice, I’ve seen veterinarians use well-calibrated scales for accuracy—guesswork has no place here. A small adjustment up or down can tip the balance toward harm. Keeping detailed records goes from tedious to essential; public audits sometimes catch slip-ups in farm logs, a warning that accountability needs teeth.
Withdrawal time means the waiting period before animal products, like meat or eggs, leave the farm and reach the market. Skipping or misjudging this step means consumers might eat furaltadone residues, which poses health concerns. The regulatory gap becomes obvious at local markets or in countries where food safety inspectors rarely visit rural farms. I’ve stood next to farmers wrestling with harvest deadlines, asking if they could “get away” with shorter withdrawal periods to fill sudden orders. My answer: not worth the risk, especially with furaltadone, since residues get picked up in routine market testing more often than many realize. Holding the line on food safety keeps trust in the food chain intact.
Effective use starts with a solid diagnosis. Animals don’t need furaltadone for every cough or gut issue, so vets run tests first, often growing bacteria in a lab to see which drug targets the culprit. Rushing into treatment saves a day but damages the big picture by encouraging resistance down the line. I still recall a fish farmer in Southeast Asia explaining how years of preventive antibiotics led to completely resistant strains—now, he works with specialists to monitor water quality and boost fish immunity as the main defense instead of reaching for medication.
Education changes outcomes. I’ve organized workshops for producers struggling with label instructions printed in small fonts or languages they don’t read. Translating guidelines and offering side-by-side demonstrations helps cut confusion, especially for smallholders. Regulators and industry players need open lines, not just warning letters—it’s the one thing that pushes toward safer practices, farm by farm. Tracking antibiotics from drugstore to animal, then to market, helps root out misuse. Digital recordkeeping tools, even a simple spreadsheet, make a real difference in catching mistakes early. Clear information at every level—the farm, the veterinarian, the regulator—keeps the system honest and protects both animal and human health.
Furaltadone once played a big part in animal farming. It worked as an antibiotic, keeping infections down and growth rates up. As someone who covered news in rural towns, I saw how veterinarians counted on it after tough outbreaks. Stories from livestock keepers showed just how much they wanted quick cures for sick flocks. Things changed fast when scientists pointed to worrying side effects. It turned out residues of Furaltadone in meat or fish might hurt people, making food safety a public concern. The European Union and the United States, among others, scrapped its approval for farming years ago. They didn’t want to risk carcinogenic effects or the rise of antibiotic resistance.
Picking safety over convenience rarely goes down easy. Countries like those in the EU began monitoring food imports, adding Furaltadone to a list of banned nitrofuran drugs. Not every country jumped on board, though. Places with less cash or weaker enforcement stuck with the old routine. Health authorities got worried about cancer risk—lab rats exposed to nitrofurans showed clear links. The World Health Organization recognized the danger, and regulators hammered out strict residue limits. I once spoke with a chicken farmer who was confused by mixed local guidelines and struggled to afford alternative medicines. That sort of uncertainty, with no clear rules, felt as risky as using the drug itself.
The idea of antibiotics creating “superbugs” plays out far from labs. Researchers watched bacteria grow stronger each time farmers dosed livestock with Furaltadone. Everyone pays the price for this kind of short-term thinking. When neighbors on both sides of a border raise animals, resistant bugs don’t read maps. Health authorities everywhere started to realize that leaving some areas unchecked hurt everyone. There’s data showing foodborne pathogens not only survive these antibiotics but thrive if exposed often enough. In crowded places, that means outbreaks hit faster and harder.
Banning Furaltadone puts a real burden on farmers. Some governments stepped up, funding alternative treatment and better hygiene programs. Others sent experts to teach about safe feed and less risky drugs. This kind of investment works in rich places with deep pockets. In low-income countries, fewer resources can mean farmers turn to black-market antibiotics or skip disease control altogether. I watched health workers try to fill the gap with education, stressing the long-term benefits for everyone who sits down to eat.
The Furaltadone ban raised the bar for food producers—and shook up global supply chains. Supermarket buyers and home cooks want reassurance that food won’t make them sick. Quick residue tests, traceability programs, and clear labeling are steps in a direction that builds trust. Global export markets started demanding proof of zero nitrofuran residues, opening doors only to those willing to meet higher standards. Supporting these shifts means stronger labs, transparent systems, and fair prices for smallholder farmers. The safer the food, the more buyers lean in. For consumers, each meal comes with a bit more confidence.
| Names | |
| Preferred IUPAC name | N-(5-nitrofurfurylidene)-3-oxo-butanehydrazide |
| Other names |
Furaltadone hydrochloride Furaltadone HCl N-(5-nitro-2-furfurylidene)-1-aminohydantoin |
| Pronunciation | /fjʊˌræl.təˈdoʊn/ |
| Identifiers | |
| CAS Number | 69-94-9 |
| 3D model (JSmol) | `3D model (JSmol)` string for **Furaltadone**: ``` COC1=CC=C(C=C1)C(=O)NCCN(CCO)C2=CC=C(NO2)C=O ``` *(This is the SMILES string for Furaltadone, suitable for use in JSmol and other molecular modeling software.)* |
| Beilstein Reference | 136232 |
| ChEBI | CHEBI:31615 |
| ChEMBL | CHEMBL1561 |
| ChemSpider | 21502 |
| DrugBank | DB13332 |
| ECHA InfoCard | 100.044.507 |
| EC Number | EC 4.2.1.17 |
| Gmelin Reference | 83507 |
| KEGG | C14537 |
| MeSH | D005670 |
| PubChem CID | 4035 |
| RTECS number | RT0175000 |
| UNII | 9D02RH8K0A |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C12H16N4O6 |
| Molar mass | 236.15 g/mol |
| Appearance | Yellow crystalline powder |
| Odor | Odorless |
| Density | 1.5 g/cm³ |
| Solubility in water | Slightly soluble |
| log P | 0.01 |
| Vapor pressure | 9.13E-10 mm Hg at 25°C |
| Acidity (pKa) | 7.59 |
| Basicity (pKb) | 7.06 |
| Refractive index (nD) | 1.720 |
| Dipole moment | 4.85 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 439.3 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -232.8 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -4053.1 kJ/mol |
| Pharmacology | |
| ATC code | QJ01XE03 |
| Hazards | |
| Main hazards | Suspected of causing cancer |
| GHS labelling | GHS02, GHS07 |
| Pictograms | flame, health hazard, exclamation mark, environment |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. H317: May cause an allergic skin reaction. |
| Precautionary statements | P264, P270, P273, P301+P312, P330, P501 |
| Flash point | 100°C |
| Lethal dose or concentration | LD50 (oral, mouse): 1000 mg/kg |
| LD50 (median dose) | LD50 (median dose) of Furaltadone: 1280 mg/kg (oral, mouse) |
| NIOSH | VJ8225000 |
| PEL (Permissible) | 0.5 mg/kg |
| REL (Recommended) | 0.01 – 0.02 mg/kg bw |
| Related compounds | |
| Related compounds |
Nitrofurantoin Nitrofurazone Furazolidone Nifuratel |
